Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons

Molecular Brain Research

Volumn 66, Issue 1-2, 1999, Pages 62-70

  Feng, Linyin ^a,b   Wang, Chang Yu ^a,c   Jiang, Hao ^a   Oho, Chikara ^a   Mizuno, Keiko ^a   Dugich Djordjevic, Millicent ^a   Lu, Bai ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

BDNF; Fasciculation; GDNF; Mesencephalic; Synaptic protein; Transmitter release

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTRANSMITTER; NEUROTROPHIC FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYO; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; NERVE CELL CULTURE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACTINS; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CILIARY NEUROTROPHIC FACTOR; DOPAMINE; FETUS; GAMMA-AMINOBUTYRIC ACID; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MEMBRANE PROTEINS; MESENCEPHALON; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; R-SNARE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; SYNAPSINS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 0033586409     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00015-7     Document Type: Article

References (65)

1. Altar C.A., Boylan C.B., Fritsche M., Jackson C., Hyman C., Lindsay R.M. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp. Neurol. 130:1994;31-40.
2. Altar C.A., Boylan C.B., Jackson C., Hershenson S., Miller J., Wiegand S.J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc. Natl. Acad. Sci. USA. 89:1992;11347-11351.
3. Arenas E., Akerud P., Wong V., Boylan C., Persson H., Lindsay R.M., Altar C.A. Effects of BDNF and NT-4/5 on striatonigral neuropeptides or nigral GABA neurons in vivo. Eur. J. Neurosci. 8:1996;1707-1717.
4. Baloh R.H., Tansey M.G., Golden J.P., Creedon D.J., Heuckeroth R.O., Keck C.L., Zimonjic D.B., Popescu N.C., Johnson E.J., Milbrandt J. TrnR2, a novel receptor that mediates neurturin and GDNF signaling through Ret. Neuron. 18:1997;793-802.
5. Barbacid M. Nerve growth factor: a tale of two receptors. Oncogene. 8:1993;2033-2042.
6. Beck K.D., Irwin I., Valverde J., Brennan T.J., Brennan W., Brennan L.J., Hefti F. GDNF Induces a dystonia-like state in neonatal rats and stimulates dopamine and serotonin synthesis. Neuron. 16:1996;665-673.
7. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
8. Blochl A., Sirrenberg C. Neurotrophins stimulate the release of dopamine from rat mesencephalic neurons via Trk and p75Lntr receptors. J. Biol. Chem. 271:1996;21100-21107.
9. Bowenkamp K.E., Hoffman A.F., Gerhardt G.A., Henry M.A., Biddle P.T., Hoffer B.J., Granholm A.C. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:1995;479-489.
10. Buj-Bello A., Adu J., Pinon L.G., Horton A., Thompson J., Rosenthal A., Chinchetru M., Buchman V.L., Davies A.M. Neurturin responsiveness requires a GPI-linked receptor and the Ret receptor tyrosine kinase. Nature. 387:1997;721-724.
11. Cass W.A. GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine. J. Neurosci. 16:1996;8132-8139.
12. Chao M.V. Neurotrophin receptors: a window into neuronal differentiation. Neuron. 9:1992;583-593.
13. Choi-Lundberg D.L., Lin Q., Chang Y.-N., Chiang Y.L., Hay C.M., Morrison P.F., Dedrick R.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
14. Collazo D., Takahashi H., MaKay R.D.G. Cellular targets and trophic functions of neurotrophin-3 in the developing rat hippocampus. Neuron. 9:1992;643-656.
15. Durbec P., Marcos G.C., Kilkenny C., Grigoriou M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Costantini F., Saarma M., Sariola H., Pachnis V. GDNF signalling through the Ret receptor tyrosine kinase. Nature. 381:1996;789-793.
16. Galpern W.R., Frim D.M., Tatter S.B., Altar C.A., Beal M.F., Isacson O. Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration. Cell Transplant. 5:1996;225-232.
17. Gao W., Dugich-Djordjevic M.M., Weil R.J., Lu B. Therapeutical usage of neurotrophic factors: patent analysis. Expert Opin. Therap. Patents. 7:1997;325-338.
18. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
19. Hefti F. Pharmacology of neurotrophic factors. Ann. Rev. Pharmacol. Toxicol. 37:1997;239-267.
20. Herbert M.A., Horne C.G.V., Hoffer B.J., Gerhardt G.A. Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J. Pharm. Expt. Ther. 279:1996;1181-1190.
21. Hoffer B.J., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L.F., Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:1994;107-111.
22. Hoffman A.F., van Horne C.G., Eken S., Hoffer B.J., Gerhardt G.A. In vivo microdialysis studies on somatodendritic dopamine release in the rat substantia nigra: effects of unilateral 6-OHDA lesions and GDNF. Exp. Neurol. 147:1997;130-141.
23. Hudson J., Granholm A.C., Gerhardt G.A., Henry M.A., Hoffman A., Biddle P., Leela N.S., Mackerlova L., Lile J.D., Collins F.et al. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36:1995;425-432.
24. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
25. Hyman C., Juhasz M., Jackson C., Wright P., Ip N., Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14:1994;335-347.
26. Ip N.Y., Li Y., Yancopoulos G., Lindsay R. Cultured hippocampal neurons show responses to BDNF, NT-3, and NT-4, but not NGF. J. Neurosci. 13:1993;3394-3405.
27. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
28. Jing S., Yu Y., Fang M., Hu Z., Holst P.L., Boone T., Delaney J., Schultz H., Zhou R., Fox G.M. GFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem. 272:1997;33111-33117.
29. Kearns C.M., Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:1995;104-111.
30. Klein R.D., Sherman D., Ho W.H., Stone D., Bennett G.L., Moffat B., Vandlen R., Simmons L., Gu Q., Hongo J.A., Devaux B., Poulsen K., Armanini M., Nozaki C., Asai N., Goddard A., Phillips H., Henderson C.E., Takahashi M., Rosenthal A. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature. 387:1997;717-721.
31. Knusel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nikolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA. 88:1991;961-965.
32. Lapchak P.A., Jiao S., Miller P.J., Williams L.R., Cummins V., Inouye G., Matheson C.R., Yan Q. Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell Tissue Res. 286:1996;179-189.
33. Levivier M., Przedborski S., Bencsics C., Kang U.J. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15:1995;7810-7820.
34. Lewin G.R., Barde Y.-A. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19:1996;289-317.
35. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
36. Lin L.F., Zhang T.J., Collins F., Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
37. Lindsay R.M., Altar C.A., Cedarbaum J.M., Hyman C., Wiegand S.J. The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease. Experimental Neurology. 124:1993;103-118.
38. Martin I.M., Altar C.A. Spontaneous behaviours of rats are differentially affected by substantia nigra infusions of brain-derived neurotrophic factor and neurotrophin-3. Eur. J. Neurosci. 8:1996;1696-1706.
39. McAlhany R.J., West J.R., Miranda R.C. Glial-derived neurotrophic factor rescues calbindin-D28k-immunoreactive neurons in alcohol-treated cerebellar explant cultures. J. Neurobiol. 33:1997;835-847.
40. Milbrandt J., de Sauvage F.J., Fahrner T.J., Baloh R.H., Leitner M.L., Tansey M.G., Lampe P.A., Heuckeroth R.O., Kotzbauer P.T., Simburger K.S., Golden J.P., Davies J.A., Vejsada R., Kato A.C., Hynes M., Sherman D., Nishimura M., Wang L.C., Vandlen R., Moffat B., Klein R.D., Poulsen K., Gray C., Garces A., Johnson E.M. Jr.et al. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 20:1998;245-253.
41. 3H ] GABA release from cerebral cortical neurons is mediated by peroxynitrite J. Neurochem. 65:1995;1109-1114.
42. 2+ binding protein frequenin is a nervous system-specific protein preferentially localized in neurites. Mol. Brain Res. 44:1997;73-82.
43. Perez N.E., Arenas E., Reiriz J., Calvo N., Alberch J. Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage. Neuroscience. 75:1996;345-352.
44. Pothos E.N., Davila V., Sulzer D. Presynaptic recording of quanta from midbrain dopamine neurons and modulation of the quantal size. J. Neurosci. 18:1998;4106-4118.
45. Sanicola M., Hession C., Worley D., Carmillo P., Ehrenfels C., Walus L., Robinson S., Jaworski G., Wei H., Tizard R., Whitty A., Pepinsky R.B., Cate R.L. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc. Natl. Acad. Sci. USA. 94:1997;6238-6243.
46. Sauer H., Rosenblad C., Bjorklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc. Natl. Acad. Sci. USA. 92:1995;8935-8939.
47. Shen L., Figourov A., Lu B. Recent progress in studies of neurotrophic factors and their clinical implications. J. Mol. Medicine. 75:1997;637-644.
48. Shults C.W., Kimber T., Altar C.A. BDNF attenuates the effects of intrastriatal injection of 6-hydroxydopamine. NeuroReport. 6:1995;1109-1112.
49. Sinclair S.R., Svendsen C.N., Torres E.M., Martin D., Fawcett J.W., Dunnett S.B. GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. NeuroReport. 7:1996;2547-2552.
50. Skaper S.D., Negro A., Facci L., Dal T.R. Brain-derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5-trihydroxyphenylalanine-induced injury. J. Neurosci. Res. 34:1993;478-487.
51. Spina M.B., Squinto S.P., Miller J., Lindsay R.M., Hyman C. Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59:1992;99-106.
52. Studer L., Spenger C., Seiler R.W., Altar A., Lindsay R.M., Hyman C. Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur. J. Neurosci. 7:1995;223-233.
53. Sudhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature. 375:1995;645-653.
54. Suvanto P., Wartiovaara K., Lindahl M., Arumae U., Moshnyakov M., Horelli K.N., Airaksinen M.S., Palotie A., Sariola H., Saarma M. Cloning, mRNA distribution and chromosomal localisation of the gene for glial cell line-derived neurotrophic factor receptor beta, a homologue to GDNFR-alpha. Hum. Mol. Genet. 6:1997;1267-1273.
55. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
56. Treanor J.J., Goodman L., de S.F., Stone D.M., Poulsen K.T., Beck C.D., Gray C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj B.A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-83.
57. Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., Kilkenny C., Salazar G.E., Pachnis V., Arumae U., Sariola H., Saarma M., Ibanez C.F. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:1996;785-788.
58. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-α indicates multiple mechanisms of trophic actions in the adult rat CNS. J. Neurosci. 15:1997;3554-3567.
59. Trupp M., Ryden M., Jornvall H., Funakoshi H., Timmusk T., Arenas E., Ibanez C. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J. Cell Biol. 130:1995;137-148.
60. Tsukahara T., Takeda M., Shimohama S., Ohara O., Hashimoto N. Effects of brain-derived neurotrophic factor on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in monkeys. Neurosurgery. 37:1995;733-739.
61. Wang C.-Y., Ni J., Jiang H., Hsu T.-A., Dugich-Djordjevic M., Feng L., Zhang M., Mei L., Gentz R., Lu B. Cloning and characterization of GDNF receptor beta: a novel receptor for members of GDNF family of neurotrophic factors. Neuroscience. 83:1998;7-14.
62. Widenfalk J., Nosrat C., Tomac A., Westphal H., Hoffer B., Olson L. Neurturin and glial cell line-derived neurotrophic factor receptor-beta (GDNFR-beta), novel proteins related to GDNF and GDNFR-alpha with specific cellular patterns of expression suggesting roles in the developing and adult nervous system and in peripheral organs. J. Neurosci. 17:1997;8506-8519.
63. Winkler C., Sauer H., Lee C.S., Bjorklund A. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 16:1996;7206-7215.
64. Yan Q., Radeke M.J., Matheson C.R., Talvenheimo J., Welcher A.A., Feinstein S.C. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J. Comp. Neurol. 378:1997;135-157.
65. Yoshimoto Y., Lin Q., Collier T.J., Frim D.M., Breakefield X.O., Bohn M.C. Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain. Res. 691:1995;25-36.